Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4555 |  MRKR Marker Therapeutics, Inc. - Common Stock | 1.62 USD | -3.57% | +9.46% | +10.96% | -1.82% | 27.01 M USD | ||
| 4566 |  PSTV PLUS THERAPEUTICS, Inc. - Common Stock | 3.71 USD | -5.36% | -17.00% | -31.42% | +1024.24% | 25.54 M USD | ||
| 4567 |  KALA KALA BIO, Inc. - Common Stock | 1.37 USD | -9.27% | -23.46% | -41.45% | -73.40% | 25.47 M USD | ||
| 4570 |  SKYE Skye Bioscience, Inc. - Common Stock | 0.71 USD | +1.43% | +2.90% | -7.79% | -11.25% | 24.95 M USD | ||
| 4571 |  BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.61 USD | -3.17% | -7.58% | -17.57% | -40.20% | 24.92 M USD | ||
| 4588 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 5.36 USD | -2.55% | -12.42% | -54.88% | +335.77% | 22.45 M USD | ||
| 4611 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.69 USD | -4.17% | -4.17% | -15.85% | -67.14% | 22.46 M USD | ||
| 4613 |  VYNE VYNE Therapeutics Inc. - Common Stock | 0.65 USD | -2.99% | -2.99% | -2.99% | -52.90% | 21.68 M USD | ||
| 4615 |  CELU Celularity Inc. - Class A Common Stock | 0.77 USD | +5.48% | +22.22% | -3.75% | -59.26% | 22.29 M USD | ||
| 4629 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.63 USD | -2.59% | -6.41% | +5.20% | -16.24% | 21.02 M USD | ||
| 4632 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.46 USD | -1.20% | +23.62% | -45.93% | +192.86% | 21.18 M USD | ||
| 4633 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.86 USD | -1.83% | -9.24% | +8.34% | +119.83% | 20.82 M USD | ||
| 4643 |  PLUR Pluri Inc. - Common Stock | 1.91 USD | -7.73% | -8.61% | -19.07% | -50.00% | 20.61 M USD | ||
| 4655 |  ICU SeaStar Medical Holding Corporation - Common Stock | 4.94 USD | -2.56% | +9.53% | +70.93% | +100.81% | 19.75 M USD | ||
| 4657 |  LPCN Lipocine Inc. - Common Stock | 2.40 USD | -2.83% | +0.42% | +17.65% | -17.24% | 19.79 M USD | ||
| 4660 |  LGVN Longeveron Inc. - Class A Common stock | 0.64 USD | 0.00% | -14.67% | -14.67% | +12.28% | 19.93 M USD | ||
| 4663 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.40 USD | -5.29% | -23.94% | -26.72% | -54.05% | 18.38 M USD | ||
| 4671 |  NCEL NewcelX Ltd. - Ordinary Shares | 4.18 USD | +4.24% | +4.50% | +32.70% | -17.72% | 20.05 M USD | ||
| 4677 |  PTN Palatin Technologies, Inc. Common Stock | 10.55 USD | -4.00% | +2.93% | -24.86% | +45.52% | 18.77 M USD | ||
| 4683 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.71 USD | 0.00% | 0.00% | -1.39% | -31.73% | 18.68 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |